A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator promoting prostate cancer proliferation.
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 30 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 30 samples: 30 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE335783_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1479436 and SRA study SRP710437. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 30 sample titles: 30 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9820947 LNCaP-Clone78 Input (DMSO/EtOH)
- GSM9820948 LNCaP-Clone78 Input (DMSO/R1881)
- GSM9820949 LNCaP-Clone78 Input (DOX/EtOH)
- GSM9820950 LNCaP-Clone78 Input (DOX/R1881)
- GSM9820951 LNCaP-Clone21 Input (DMSO/EtOH)
- GSM9820952 LNCaP-Clone21 Input (DMSO/R1881)
- GSM9820953 LNCaP-Clone21 Input (DOX/EtOH)
- GSM9820954 LNCaP-Clone21 Input (DOX/R1881)
- GSM9820955 LNCaP-Clone78 AR ChIP (DMSO/EtOH)
- GSM9820956 LNCaP-Clone78 AR ChIP (DMSO/R1881)
- GSM9820957 LNCaP-Clone78 AR ChIP (DOX/EtOH)
- GSM9820958 LNCaP-Clone78 AR ChIP (DOX/R1881)
- GSM9820959 LNCaP-Clone21 AR ChIP (DMSO/EtOH)
- GSM9820960 LNCaP-Clone21 AR ChIP (DMSO/R1881)
- GSM9820961 LNCaP-Clone21 AR ChIP (DOX/EtOH)
- GSM9820962 LNCaP-Clone21 AR ChIP (DOX/R1881)
- GSM9820963 LNCaP-Clone78 METTL3 ChIP (DMSO/EtOH)
- GSM9820964 LNCaP-Clone78 METTL3 ChIP (DMSO/R1881)
- GSM9820965 LNCaP-Clone78 METTL3 ChIP (DOX/EtOH)
- GSM9820966 LNCaP-Clone78 METTL3 ChIP (DOX/R1881)
- GSM9820967 LNCaP-Clone21 METTL3 ChIP (DMSO/EtOH)
- GSM9820968 LNCaP-Clone21 METTL3 ChIP (DMSO/R1881)
- GSM9820969 LNCaP-Clone21 METTL3 ChIP (DOX/EtOH)
- GSM9820970 LNCaP-Clone21 METTL3 ChIP (DOX/R1881)
- GSM9820971 22Rv1 Input (Whole media)
- GSM9820972 22Rv1 AR ChIP (Whole media)
- GSM9820973 22Rv1 METTL3 ChIP (Whole media)
- GSM9820974 LNCaP Input (Whole media)
- GSM9820975 LNCaP AR ChIP (Whole media)
- GSM9820976 LNCaP METTL3 ChIP (Whole media)
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE240672 METTL3 in prostate cancer cells 20 samples shares mettl3, prostate
- GSE298598 METTL3/YTHDF2 axis inhibits cell proliferation and fibrosis by degrading the N6-methyladenosine modification of TCF7L2-Smad2/Smad3 mRNA in pterygium 12 samples shares mettl3, proliferation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.